SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020917
Filing Date
2020-11-10
Accepted
2020-11-10 16:00:45
Documents
53
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 856646
2 ex31-1.htm EX-31.1 11290
3 ex31-2.htm EX-31.2 11139
4 ex32-1.htm EX-32.1 7048
5 ex32-2.htm EX-32.2 7236
  Complete submission text file 0001493152-20-020917.txt   3185212

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ogen-20200930.xml EX-101.INS 373722
7 XBRL SCHEMA FILE ogen-20200930.xsd EX-101.SCH 46418
8 XBRL CALCULATION FILE ogen-20200930_cal.xml EX-101.CAL 40155
9 XBRL DEFINITION FILE ogen-20200930_def.xml EX-101.DEF 133202
10 XBRL LABEL FILE ogen-20200930_lab.xml EX-101.LAB 295753
11 XBRL PRESENTATION FILE ogen-20200930_pre.xml EX-101.PRE 211223
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 201301039
SIC: 2834 Pharmaceutical Preparations